Orotic Acid, More Than Just an Intermediate of Pyrimidine de novo Synthesis

Journal of Genetics and Genomics

Volumn 42, Issue 5, 2015, Pages 207-219

  Löffler, Monika ^a   Carrey, Elizabeth A ^b   Zameitat, Elke ^a  

^a PHILIPPS UNIVERSITY MARBURG   (Germany)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

Gene defects; Miller syndrome; Orotic acid; Orotic aciduria; Pyrimidines

Indexed keywords

DIHYDROOROTATE DEHYDROGENASE; OROTIC ACID; PYRIMIDINE DERIVATIVE; PYRIMIDINE NUCLEOTIDE; SYNTHETASE; UNCLASSIFIED DRUG; URIDINE; URIDINE PHOSPHATE; URIDINE PHOSPHATE SYNTHETASE; ENZYME; PYRIMIDINE;

CENTRAL NERVOUS SYSTEM; DISORDERS OF AMINO ACID AND PROTEIN METABOLISM; ERYTHROCYTE; GENETIC DISORDER; HUMAN; LIVER CELL; METABOLIC SYNDROME X; MILK; MILLER SYNDROME; NEONATAL HYPERBILIRUBINEMIA; NONHUMAN; OROTIC ACIDURIA; PYRIMIDINE SYNTHESIS; REVIEW; TRANSCRIPTION REGULATION; UREA CYCLE; ANIMAL; BIOSYNTHESIS; METABOLISM;

ANIMALS; CENTRAL NERVOUS SYSTEM; ENZYMES; HUMANS; MILK; OROTIC ACID; PYRIMIDINES;

EID: 84947020825     PISSN: 16738527     EISSN: 18735533     Source Type: Journal    
DOI: 10.1016/j.jgg.2015.04.001     Document Type: Review

References (132)

1. Ahmed A.A., Porter G.A., McCarthy R.D. Isolation, quantification, and biosynthetic origin of orotic acid in milk. J. Dairy Sci. 1978, 61:39-43.
2. Akiho H., Iwai A., Katoh-Sudoh M., Tsukamoto S., Koshiya K., Yamaguchi T. Post-ischaemic treatment with orotic acid prevented neuronal injury in gerbil brain ischaemia. Neuroreport 1997, 8:607-610.
3. Akiho H., Iwai A., Katoh-Sudoh M., Tsukamoto S., Koshiya K., Yamaguchi T. Neuroprotective effect of Y-39558, orotic acid ethylester, in gerbil forebrain ischemia. Jpn. J. Pharmacol. 1998, 76:441-444.
4. Akiho H., Iwai A., Tsukamoto S., Koshiya K., Yamaguchi T. Neuro-protective effect of YM-39558 in focal cerebral ischemia in cats. Neuropharmacology 1998, 37:159-168.
5. Akalin A.S., Gönc S. The determination of orotic acid in ruminant milk using HPLC. Milchwissenschaft 1996, 51:554-556.
6. Alonso E., Rubio V. Orotic aciduria due to arginine deprivation: changes in the levels of carbamoyl phosphate and of other urea cycle intermediates in mouse liver. J. Nutr. 1989, 119:1188-1195.
7. Angeletti P.C., Engler J.A. Adenovirus preterminal protein binds to the CAD enzyme at active sites of viral DNA replication on the nuclear matrix. J. Virol. 1998, 72:2896-2904.
8. Bach I., Kumberger O., Schmidbaur H. Synthesis and crystal structure of lithium orotate (-1) monohydrate and magnesium bis [orotate(-1)] octahydrate. Chem. Ber. 1990, 123:2267-2271.
9. Bachstez M. Über die Konstitution der Orotsäure. Berichte der Chemie 1930, 63:1000-1007.
10. Ballard E., Johnson T.B. Synthesis of derivatives of pyrimidine-5-carboxylic acid. J. Am. Chem. Soc. 1942, 64:795-796.
11. Balasubramaniam S., Duley J.A., Christodoulou J. Inborn errors of pyrimidine metabolism: clinical update and therapy. J. Inherit. Metab. Dis. 2014, 37:687-698.
12. Bernstein B.A., Richardson T., Amundson C.H. Inhibition of cholesterol biosynthesis and acetyl-coenzyme A synthetase by bovine milk and orotic acid. J. Dairy Sci. 1977, 60:1846-1853.
13. Biscaro G., Belloni E. About a new compound of the milk. Annuario della Soc. Chimica di Milano 1905, 11:15.
14. Blázquéz L.C., Flores J.r., Jara F.V., Misiego A.S. Determination of orotic acid (Vitamin B13) in milk by differential pulse polarography (DPP). Fresenius J. Anal. Chem. 1990, 338:80-81.
15. Boguslawski W., Wrobel J. An inhibitor of sterol biosynthesis in cow's milk. Nature 1974, 247:210-211.
16. Bonham J.R., Guthrie P., Downing M., Allen J.C., Tanner M.S., Sharrard M., Rittey C., Land J.M., Fensom A., O'Neill D., Duley J.A., Fairbanks L.D. The allopurinol load test lacks specificity for primary urea cycle defects but may indicate unrecognized mitochondrial disease. J. Inherit. Metab. Dis. 1999, 22:174-184.
17. Brosnan M.E., Brosnan J.T. Orotic acid excretion and arginine metabolism. J. Nutr. 2007, 137:1656S-1661S.
18. Brusilow A.W., Hauser E. Simple method of measurement of orotic acid and orotidine in urine. J. Chromatogr. 1989, 493:388-391.
19. Buang Y. Dietary adenine alleviates fatty liver induced by orotic acid. Indo. J. Chem. 2010, 10:363-369.
20. Butour J.L., Wimmer S., Wimmer F., Castan P. Palladium (II) compounds with potential antitumour properties and their platinum analogues: a comparative study of the reaction of some orotic derivatives with DNA in vitro. Chem. Biol. Interact. 1997, 104:165-178.
21. Cansev M. Uridine and cytidine in the brain: their transport and utilization. Brain Res. Rev. 2006, 52:390-397.
22. Carpenter K.H., Potter M., Hammond J.W., Wilcken B. Benign persistent orotic aciduria and the possibility of misdiagnosis of ornithine carbamoly transferase deficiency. J. Inherit. Metab. Dis. 1997, 20:354-358.
23. Carrey E.A., Dietz C., Glubb D.M., Löffler M., Lucocq J.M., Watson P.F. Detection and location of the enzymes of de novo pyrimidine biosynthesis in mammalian spermatozoa. Reproduction 2002, 123:757-768.
24. Christopherson R.I., Jones M.E. The overall synthesis of L-5,6-dihydroorotate by multienzymatic protein pyr1-3 from hamster cells. Kinetic studies, substrate channeling, and the effects of inhibitors. J. Biol. Chem. 1980, 255:11381-11395.
25. Conner T.W., Rawls J.M. Analysis of the phenotypes exhibited by rudimentary-like mutants of Drosophila melanogaster. Biochem. Genet. 1982, 20:607-619.
26. Connolly G.P., Duley J.A. Uridine and its nucleotides: biological actions, therapeutic potentials. Trends Pharmacol. Sci. 1999, 20:218-225.
27. Cortes P., Levin N.W., Dumler F., Venkatachalam K.K., Verghese C.P., Bernstein J. Incorporation of exogenous precursors into uridine nucleotides and ribonucleic acid. Nucleotide compartmentation in the renal cortex in vivo. Biochem. J. 1979, 182:677-686.
28. Dalbeth N., Wong S., Gamble G.D., Horne A., Mason B., Pool B., Fairbanks L., McQueen F.M., Cornish J., Reid I.R., Palmano K. Acute effect of milk on serum urate concentration: a randomized control cross-over trail. Ann. Rheum. Dis. 2010, 69:1677-1682.
29. Durschlag R.P., Robinson J.L. Orotic acid-induced metabolic changes in the rat. J. Nutr. 1980, 110:816-821.
30. Ehle F.R., Robinson J.L., Clark J.H., Baumrucker C.R. Effect of amino acid concentration on orotic acid production by bovine mammary tissue. J. Dairy Sci. 1981, 64:2192-2196.
31. Eisenberg M., Kirkpatrick R., Rawls J. Structure of the rudimentary-like gene and UMP synthase in Drosophila melanogaster. Gene 1993, 124:263-267.
32. European Food Safety Authority Orotic acid salts as sources of orotic acid and various minerals added for nutritional purposes to food supplements. EFSA J. 2009, 1187:1-25.
33. Evans D.R., Guy H.I. Mammalian pyrimidine biosynthesis: fresh insights into an ancient pathway. J. Biol. Chem. 2004, 279:33035-33038.
34. Fabbrizzi L., Licchelli M., Mancin F., Pizzeghello M., Rabaioli G., Taglietti A., Tecilla P., Tonellato U. Fluorescence sensing of ionic analytes in water: from transition metal ions to vitamin B13. Chem-Eur. J. 2002, 8:94-101.
35. Fang J.X., Uchiumi T., Yagi M., Matsumoto S., Amamoto R., Saito T., Takazaki S., Kanki T., Yamaza H., Nonaka K., Kang D. Protein instability and functional defects caused by mutations of dihydroorotate dehydrogenase in Miller syndrome patients. Biosci. Rep. 2012, 32:631-639.
36. Falk M. Orotsäure. Die Pharmazie 1985, 40:377-383.
37. Ferdinandy P., Fazekas T., Kádár E. Effects of orotic acid on ischaemic/reperfused myocardial function and glycogen content in isolated working rat hearts. Pharmacol. Res. 1998, 37:111-114.
38. Ferrari V., Giordano G., Cracco A.T., Chiandeti L., Zacchello F. Determination of urinary orotate excretion by high-performance liquid chromatography. J. Chromatogr. 1989, 497:101-107.
39. Fico M.E., Motyl T., Milner J.A. Species comparison of the influence of ammonia on orotic acid and urea biosynthesis in liver. J. Nutr. 1984, 114:613-621.
40. Fukushima R., Kanamori S., Hirashiba M., Hishikawa A., Muranaka R.I., Kaneto M., Nakamura K., Kato I. Teratogenicity study of the dihydroorotate dehydrogenase inhibitor and protein tyrosine kinase inhibitor leflunomide in mice. Reprod. Toxicol. 2007, 24:310-316.
41. Fukushima R., Kanamori S., Hirashiba M., Hishikawa A., Muranaka R., Kaneto M., Kitagawa H. Inhibiting the teratogenicity of the immunosuppressant leflunomide in mice by supplementation of exogenous uridine. Toxicol. Sci. 2009, 108:419-426.
42. Geiss K.R., Stergiou N., Neuenfeldt H.U., Jester H.G. Effects of magnesium orotate on exercise tolerance in patients with coronary heart disease. Cardiovasc. Drug Ther. 1998, 12:153-156.
43. Gerlach J., Löffler M., Schäfer M.K.H. Gene expression of enzymes required for the de novo synthesis and degradation of pyrimidines in rat peripheral tissues and brain. Nucleos. Nucleot. Nucl. 2011, 30:1147-1154.
44. Gil A., Sànchez-Medina F. Acid-soluble nucleotides of cow's, goat's and sheep's milk at different stages of lactation. J. Dairy Res. 1981, 48:35-44.
45. Gilissen C., Hoischen A., Brunner H.G., Veltman J.A. Unlocking Mendelian disease using exome sequencing. Genome Biol. 2011, 12:228-238.
46. Griffin J.L., Bonney S.A., Mann C., Hebbachi A.M., Gibbons G.F., Nicholson J.K., Shoulders C.C., Scott J. An integrated reverse functional genomic and metabolic approach to understanding orotic acid-induced fatty liver. Physiol. Genomics 2004, 17:140-149.
47. Grisham C.M., Garrett R.H., Garrett R. Biochemistry 2008, Brooks Cole Publishing, Pacific Grove, USA.
48. Häberle J., Rubio V. Hyperammonemia and related disorders. Physician's Guide to the Diagnosis, Treatment and Follow-up of Inherited Metabolic Diseases 2014, 47-62. Springer-Verlag, Heidelberg, Germany. N. Blau, R. Duran, K.M. Gibson, M. Blaskovics, V. Dionisi-Vici (Eds.).
49. Hallanger L.E., Laakso J.W., Schultze M.O. Orotic acid in milk. J. Biol. Chem. 1953, 202:83-89.
50. Harley E.H., Sacks S., Berman P., Cohen L., Simmonds H.A., Fairbanks L.D., Black D. Source and fate of circulating pyrimidines. Adv. Exp. Med. Biol. 1986, 195PtA:109-113.
51. Hayek-Ouassini M., Henseling J., Löffler M. Separation of N-carbamoyl aspartate and L-dihydroorotate from serum with high-performance liquid chromatography with fluorimetric detection. Chromatographia 2002, 55:411-415.
52. Heidelberger C. Fluorinated pyrimidines. Prog. Nucleic Acid Res. Mol. Biol. 1965, 4:1-50.
53. Hinkel G.H., Le Petit G. Untersuchungen über die enterale Resorption der Orotsäure bei Neugeborenen. Padiatr. Grenzgeb. 1973, 12:63-69.
54. Hitchings G.H., Elion G.B., VanderWerff H., Falco E.A. Pyrimidine derivatives as antagonists of pteroylglutamic acid. J. Biol. Chem. 1948, 174:765-766.
55. Hong E.S., Kim E.K., Kang S.M., Khang A.R., Choi S.H., Park K.S., Jang H.C., Lim S. Effect of carnitine-orotate complex on glucose metabolism and fatty liver: a double-blind, placebo-controlled study. J. Gastroen. Hepatol. 2014, 29:1449-1457.
56. Itzhaki S. Regulation of uracil utilization for RNA synthesis in Ehrlich ascites tumor cells by glucose metabolism. Life Sci. 1972, 11:649-655.
57. Indyk H.E., Woollard D.C. Determination of orotic acid, uric acid, and creatinine in milk by liquid chromatography. J. AOAC Int. 2004, 87:116-122.
58. Jacobs C., Sweetman L., Nyhan W.L., Gruneke L., Craig J.C., Wadman S.K. Stable isotope dilution analysis of orotic acid and uracil in amniotic fluid. Clin. Chim. Acta 1984, 143:123-133.
59. Javaid Z.Z., el Kouni M.H., Iltzsch M.H. Pyrimidine nucleobase ligands of orotate phosphoribosyl transferase from Toxoplasma gondii. Biochem. Pharmacol. 1999, 58:1457-1465.
60. Jeevanadam M., Shoemaker J.D., Horowitz G.D., Lowry S.F., Brennan M.F. Orotic acid excretion during starvation and refeeding in normal men. Metabolism 1985, 34:325-329.
61. Jensen K.F., Björnberg O. Evolutionary and functional families of dihydroorotate dehydrogenase. Path Pyrimidines 1998, 6:20-28.
62. Jones M.E. Pyrimidine nucleotide biosynthesis in animals: genes, enzymes, and regulation of UMP biosynthesis. Ann. Rev. Biochem. 1980, 49:253-279.
63. Jung E.J., Kwon S.W., Jung B.H., Oh S.H., Lee B.H. Role of the AMPK/SREBP-1 pathway in development of orotic acid-induced fatty liver. J. Lipid Res. 2011, 52:1617-1625.
64. Kaneti J.J., Golovinsky E.V. Quantitative relationships between the electronic structure and biological activity of some analogues of orotic acid. Chem. Biol. Interact. 1971, 3:421-428.
65. Karatas F. An investigation of orotic acid levels in the breastmilk of smoking and non-smoking mothers. Eur. J. Clin. Nutr. 2002, 56:958-960.
66. Kelley W.N., Greene M.L., Fox I.H., Rosenbloom F.M., Levy R.I., Seegmiller J.E. Effects of orotic acid on purine and lipoprotein metabolism in man. Metabolism 1979, 19:1025-1035.
67. Keppler D., Holstege A. Pyrimidine nucleotide metabolism and its compartmentation. Metabolic Compartmentation 1982, 148-203. Academic Press, London, UK. E. Sies (Ed.).
68. Kesner L., Aronson F.L., Silverman M., Chan P.C. Determination of orotic and dihydroorotic acids in biological fluids and tissues. Clin. Chem. 1975, 21:353-355.
69. Kinoshita, S., Tanaka, K., 1963. Method for producing orotic acid by fermentation process. US Patent 3086917.
70. Kinoshita F., Kondoh T., Komori K., Matsui T., Harada N., Yanai A., Fukuda M., Morifuji K., Matsumoto T. Miller syndrome with novel dihydroorotate dehydrogenase gene mutations. Pediatr. Int. 2011, 53:587-591.
71. Kintzel H.W., Hinkel G.K., Schwarze R. The decrease in the serum bilirubin level in premature infants by orotic acid. Acta Paediatr. Scand. 1971, 60:1-5.
72. Kozhevnikova E.N., van der Knaap J.A., Pindyurin A.V., Ozgur Z., van Ijcken W.F.J., Moshkin Y.M., Verrijzer C.P. Metabolic enzyme IMPDH is also a transcription factor regulated by cellular state. Mol. Cell 2012, 47:133-139.
73. Kumberger O., Riede J., Schmidbaur H. Preparation and crystal structure of calcium and zinc orotate(2-)hydrates. Chem. Ber. 1991, 124:2739-2742.
74. Larson B.L., Hegarty H.M. Orotic acid in milks of various species and commercial dairy products. J. Dairy Sci. 1979, 62:1641-1644.
75. Latzel K. Staatsdoping. Der VEB Jenapharm im Sportsystem der DDR 2009, Böhlau Verlag, Wien, Austria.
76. Levitte S., Selesky R., King B., Smith S.C., Depper M., Cole M., Hermann G.J. A Caenorhabditis elegans model of orotic aciduria reveals enlarged lysosome-related organelles in embryos lacking umps-1 function. FEBS J. 2010, 277:1420-1439.
77. Lewan L., Petersen I., Ynger T. Incorporation of orotic acid into nucleotides and RNA in mouse organs during 60 minutes. Hoppe-Seyler's Z. Biol. Chem. 1975, 356:425-429.
78. Lieberman I., Kornberg A. Enzymatic synthesis and breakdown of a pyrimidine, orotic acid. I. Dihydroorotic dehydrogenase. Biochim. Biophys. Acta 1953, 12:223-234.
79. Lipkowitz M.S. Regulation of uric acid excretion by the kidney. Curr. Rheumatol. Rep. 2012, 14:179-188.
80. Löffler M., Carrey E.A., Zameitat E. Essential role of mitochondria in pyrimidine metabolism. Tumor Cell Metabolism: Pathways, Regulation and Biology 2015, 287-312. Springer, Wien, Austria. S. Mazurek, M. Shoshan (Eds.).
81. Löffler M., Jöckel J., Schuster G., Becker C. Dihydroorotate-ubiquinone oxidoreductase links mitochondria in the biosynthesis of pyrimidine nucleotides. Mol. Cell. Biochem. 1997, 174:125-129.
82. Löffler M., Zameitat E. Pyrimidine biosynthesis and degradation (catabolism). The Encyclopedia of Biological Chemistry 2013, Vol. III:712-718. Academic Press, Waltham.
83. Manjeshwar S., Pichiri-Coni G., Coni P., Rao P.M., Rajalakshmi S., Sarma D.S.R. Ribonucleotide reductase: a possible target for orotic acid mitoinhibition in normal hepatocytes in primary culture. Cancer Lett. 1993, 73:149-154.
84. Manjeshwar S., Rao P.M., Rajalakshmi S., Sarma D.S.R. The regulation of ribonucleotide reductase by the tumor promotor orotic acid in normal rat liver in vivo. Mol. Carcinogen. 1999, 24:188-196.
85. Manna L., Hauge S.M. A possible relationship of Vitamin B13 to orotic acid. J. Biol. Chem. 1953, 202:91-96.
86. Mentel M., Spirek M., Jorck-Ramberg D., Piskur J. Transfer of genetic material between pathogenic and food-borne yeasts. Appl. Environ. Microbiol. 2006, 72:5122-5225.
87. Merry A., Quiao M., Hasler M., Kuwabara P.E. RAD-6: pyrimidine synthesis and radiation sensitivity in Caenorhabditis elegans. Biochem. J. 2014, 458:343-353.
88. Mitchell K.J., Houlahan M.B. Investigations on the biosynthesis of pyrimidine nucleosides in Neurospora. Fed. Proc. 1947, 6:506-509.
89. Miura D., Anzai N., Jutabha P., Chanluang S., He X., Toshiyuki F., Endou H. Human urate transporter 1 (hURAT1) mediates the transport of orotate. J. Physiol. Sci. 2011, 61:253-257.
90. Morin A., Fritsch L., Mathieu J.R.R., Gilbert C., Guarmit B., Firlej V., Gallou-Kabani C., Viellefond A., Delongchamps N.B., Cabon F. Identification of CAD as an androgen receptor interactant and an early marker of prostate tumor recurrence. FASEB J. 2012, 26:460-467.
91. Motyl T., Wincenciak M., Blachowski S., Kukulska W., Grzelkowska, Podgurniak M., Kasterka K., Krzeminski J., Bartnikowska E., Skalska E. Metabolic effect of orotic acid in calves. J. Vet. Med. A 1993, 40:679-689.
92. Nath M., Vats M., Roy P. Tri- and diorganotin(IV) complexes of biologically important orotic acid: synthesis, spectroscopic studies, in vitro anti-cancer, DNA fragmentation, enzyme assays and in vivo anti-inflammatory activities. Eur. J. Med. Chem. 2013, 59:310-321.
93. Ng S.B., Buckingham K.J., Lee C., Bigham A.W., Tabor H.K., Dent K.M., Huff C.D., Shannon P.T., Jabs E.W., Nickerson D.A., Shendure J., Bamshad M.J. Exome sequencing identifies a mendelian disorder. Nat. Genet. 2010, 42:30-35.
94. Nieper H.A. Die Wirkung von Zink-Orotat. Z. Präklin. Geratrie 1974, 6:127-131.
95. Novak A.F., Hauge S.M. Isolation of an unidentified growth factor (vitamin B13) in distillers' dried solubles. J. Biol. Chem. 1948, 174:647-651.
96. Ott H.W., Dickinson A.M., van Inderstine A., Bazemore A.W., Page A.C., Folkers K. Studies related to "vitamin B13". J. Nutr. 1957, 64:525-531.
97. O'Sullivan W.J. Orotic acid. Aust. N. Z. J. Med. 1973, 3:417-423.
98. Pôrto L.C., de Castro C.H., Savergnini S.S., Santos S.H., Ferreira A.V., Cordeiro L.M., Sobrinho D.B., Santos R.A., de Almeida A.P., Botion L.M. Improvement of the energy supply and contractile function in normal and ischemic rat hearts by dietary orotic acid. Life Sci. 2012, 90:476-483.
99. Rathod O.K., Khatri A. Synthesis and antiproliferative activity of threo-5-fluoro-l-dihydroorotate. J. Biol. Chem. 1990, 265:14242-14249.
100. Rainger J., Bengani H., Campbell L., Anderson E., Sokhi K., Lam W., Riess A., Ansari M., Smithson S., Lees M., Mercer C., McKenzie K., Lengfeld T., Gener Querol B., Branney P., McKay S., Morrison H., Medina B., Robertson M., Kohlhase J., Gordon C., Kirk J., Wieczorek D., Fitzpatrick D.R. Miller (Genée-Wiedemann) syndrome represents a clinically and biochemically distinct subgroup of postaxial acrofacial dysostosis associated with partial deficiency of DHODH. Hum. Mol. Genet. 2012, 21:3969-3983.
101. Raisonnier A., Bouma M.E., Salva C., Infante R. Metabolism of orotic acid: lack of orotate phosphoribosyltransferase in rat intestinal mucosa. Eur. J. Biochem. 1981, 118:65-569.
102. Rao P.M., Nagamine Y., Roomi M.W., Rajalakshmi S., Sarma D.S.R. Orotic acid, a new promoter for experimental liver carcinogenesis. Toxicol. Pathol. 1984, 12:173-178.
103. Reichard P., Lagerkvist U. The biogenesis of orotic acid in liver slices. Acta Chem. Scand. 1953, 7:1207-1217.
104. Reiter S., Löffler W., Gröbner W., Zöllner N. Urinary oxipurinol-1-riboside excretion and allopurinol-induced orotic aciduria. Adv. Exp. Med. Biol. 1986, 195A:453-460.
105. Robinson J.L. Adenine-induced orotic aciduria in rats fed diets with and without orotic acid. Nutr. Res. 1981, 1:253-259.
106. Robinson J.L., Dombrowski D.B. Effects of orotic acid ingestion on urinary and blood parameters in humans. Nutr. Res. 1983, 3:407-415.
107. Robinson J.L., Drabik M.R., Dombrowski D.B., Clark J.H. Consequences of UMP synthase deficiency in cattle. Proc. Natl. Acad. Sci. USA 1983, 80:321-323.
108. Rosenfeldt F.L., Richards S.M., Lin Z., Pepe S., Conyers R.A. Mechanism of cardioprotective effect of orotic acid. Cardiovasc. Drug Ther. 1998, 12:159-170.
109. Rüthrich H.L., Wetzel W., Matthies H. Memory retention in old rats: improvement by orotic acid. Psychopharmacology 1983, 79:348-351.
110. Salerno C., Celli P.D.M., Finocchiaro R., Crifó C., Giradinin O. Determination of urinary orotic acid and uracil by capillary zone electrophoresis. J. Chromatogr. 1999, 734:175-178.
111. Schaefer C., Schäfer M.K.H., Löffler M. Region specific distribution of dihydroorotate dehydrogenase in the rat CNS points to pyrimidine de novo synthesis in brain. Nucleos. Nucleot. Nucl. 2010, 29:476-481.
112. Shopova M.D., Moskova-Simeonova D. Plant growth regulating activity of orotic acid and its 1-cyclohexyl and 1-phenylderivatives. Biol. Plantarum. 2000, 43:437-439.
113. Sigoillot F.D., Kotsis D.H., Serre V., Sigoillot S.M., Evans D.R., Guy H.I. Nuclear localisation and mitogen-activated protein kinase phosphorylation of the multifunctional protein CAD. J. Biol. Chem. 2005, 280:25611-25620.
114. Stephens W. Dolaeus upon the Cure of Gout by Milk-diet 1732, Osborn and Longman, London.
115. Tiemeyer W., Stohrer M., Giesecke D. Metabolites of nucleic acids in bovine milk. J. Dairy Sci. 1984, 67:723-728.
116. Traut T.W. Physiological concentrations of purines and pyrimidines. Mol. Cell. Biochem. 1994, 140:1-22.
117. Traut T.W., Jones M.E. Uracil metabolism - UMP synthesis from orotic acid or uridine and conversion to ß-alanin: enzymes and cDNA. Prog. Nucleic Acid Res. Mol. Biol. 1996, 53:1-78.
118. 3H]orotic acid incorporation into the RNA of migrating columnar cells in the rat small intestine. J. Cell Biol. 1984, 98:1619-1629.
119. Van der Knaap J.A., Kozhevnikova E.N., Langenberg K., Moshkin Y.M., Verrijzer C.P. Regulation of ecdysteroid target genes. Mol. Cell. Biol. 2010, 30:736-744.
120. Van Kuilenburg A., van Lenthe H., Löffler M., van Gennip A.H. Analysis of pyrimidine synthesis de novo intermediates in urine and dried urine filter-paper strips with HPLC-electrospray tandem mass spectrometry. Clin. Chem. 2004, 50:2117-2124.
121. Vazzoler G., Bassani N., Menin A. Treatment of hyperbilirubinemia in the newborn with orotic acid. Minerva Pediatr. 1974, 26:1046-1048.
122. Visek W. Nitrogen-stimulated orotic acid synthesis and nucleotide imbalance. Cancer Res. 1992, 152:2082-2084.
123. Voet D., Voet J.G. Biochemistry 2011, John Wiley and Sons, New York, USA.
124. Von Kügelen I. Pharmacological profiles of cloned mammalian P2Y-receptor subtypes. Pharmacol. Therapeut. 2006, 110:414-432.
125. Wang Y.M., Hu X.Q., Xue Y., Li Z.J., Yanagita T., Xue C.H. Study on possible mechanism of orotic acid-induced fatty liver in rats. Nutrition 2011, 27:571-575.
126. Webster D.R., Becroft D.M., van Gennip A.H., van Kuilenburg A.B.P. Hereditary orotic aciduria and other disorders of pyrimidine metabolism. The Metabolic and Molecular Bases of Inherited Disease 2001, Vol. II:2663-2702. Medical Publishing Division, McGraw-Hill, New York, USA.
127. Weed L.L., Edmonds M., Wilson D.W. Conversion of radioactive orotic acid into pyrimidine nucleotides of nucleic acid by slices of rat liver. P. Soc. Expt. Biol. Med. 1950, 75:192-193.
128. Wellington M., Kabir M.A., Rutschenko E. 5-fluoro-orotic acid induces chromosomal alterations in genetically manipulated strains of Candida albicans. Mycologia 2006, 98:393-398.
129. 1H-NMR Spectroscopy of body fluids: inborn errors of purine and pyrimidine metabolism. Clin. Chem. 1999, 45:539-548.
130. White R.M., Cech J., Ratanasirintrawoot S., Lin C.Y., Rahl P.B., Burke C.J., Langdon E., Tomlinson M.L., Mosher J., Kaufman C., Chen F., Long H.K., Kramer M., Datta S., Neuberg D., Granter S., Young R.A., Morrison S., Wheeler G.N., Zon L.I. DHODH modulates transcriptional elongation in the neural crest and melanoma. Nature 2011, 471:518-522.
131. Willer G.B., Lee V.M., Gregg R.G., Link B.A. Analysis of the Zebrafish perplexed mutation reveals tissue-specific roles for de novo pyrimidine synthesis during development. Genetics 2005, 170:1827-1837.
132. Wohlhueter R.M., McIvor R.S., Plagemann P.G.W. Facilitated transport of uracil and 5-fluorouracil and permeation of orotic acid into cultured mammalian cells. J. Cell. Physiol. 1980, 104:309-319.